Find a Research Lab

Research Lab Results

Results per page:

  • Cervical Cancer Research Lab

    Johns Hopkins is a member of the Specialized Program of Research Excellence (SPORE) in Cervical Cancer. With a $11.5 million grant from the National Cancer Institute, we are conducting lab, translational and clinical studies to prevent and treat cervical cancers. Previous studies have identified connections between immune system genes and HPV16. Current projects include the development of next-generation HPV vaccines to control HPV-associated precursor lesions and invasive cancer. Our dedicated researchers are working to extend the techniques used in HPV vaccine development to the creation of vaccines targeting other cancers with defined tumor antigens.
    Lab Website

    Principal Investigator

    TC Wu, MD

    Department

    Pathology

  • Anna Durbin Lab

    The Anna Durbin Lab evaluates experimental vaccines through human clinical trials. We have conducted both pediatric and adult clinical trials on vaccines for HIV, hepatitis C, HPV, influenza, malaria, dengue virus, rotavirus and other viruses. We also have a longstanding interest in better understanding the immunologic factors of dengue infection and disease. We’re working to identify the viral, host and immunologic factors that cause severe dengue illness.
    Lab Website

    Principal Investigator

    Anna P. Durbin, MD

    Department

    Medicine

  • Cervical Dysplasia Research Lab

    We are interested in how immune responses occur in the cervix. The focus of our translational research is on developing immune therapies for disease caused by human papillomavirus (HPV). HPV infection causes more cancers than any other virus in the world. Cervical cancer is the most common cancer caused by HPV, and although we have known how to screen for it for over half a century, it remains the second most common cause of cancer death in women. Although the preventive vaccines are a public health milestone, they prevent HPV infections, but are not designed to make immune responses to treat HPV. We are testing different strategies to make immune responses that could treat HPV disease. Our dedicated researchers are working to extend the techniques used in HPV vaccine development to the creation of vaccines targeting other cancers with defined tumor antigens.
    Lab Website

    Principal Investigator

    Connie L. Trimble, MD

    Department

    Gynecology and Obstetrics

  • Best Laboratory

    The Best Laboratory focus on therapeutic vaccine development for HPV-related diseases by developing a murine model of papilloma analogous to Recurrent Respiratory Papillomatosis (RRP) for testing of DNA vaccine technology. We also work to understand the immunosuppressive tumor microenvironment that facilitates RRP development, and translate this work into novel therapies and clinical practice.

    Principal Investigator

    Simon R. Best, MD

    Department

    Otolaryngology - Head and Neck Surgery

  • The Kelly Gynecologic Oncology Research Program

    Our research results in effective and quality care which has led to the development of new therapies, medications and vaccines, including the HPV vaccine — the first vaccine to prevent gynecologic cancer. Our patient satisfaction scores are among the highest in the nation, due to our commitment to safety and quality.